MedTrace Logo

Surveillance For New Lung Primaries

NCT00205413 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2015-10-02

No results posted yet for this study

Summary

This clinical research protocol proposes to perform low dose helical computed tomographic (CT) scanning in 250 high-risk patients (125/year for two years) in order to detect lung carcinomas when they are small and subject to effective curative therapies.

Conditions

Sponsors & Collaborators

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Tracey Weigel, MD · University of Wisconsin Medical School

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-09-30
Primary Completion
2006-07-31
Completion
2006-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00205413 on ClinicalTrials.gov